Tags
- Abciximab
- Acenocoumarol
- Alzheimer
- Alzheimer's disease
- An
- Anticoagulant
- Antiplatelet drug
- Antithrombotic
- Apixaban
- Approval
- Aspirin
- Await
- Base pair
- Bone marrow
- Brain
- Carcinoma
- Chromosome
- Chromosome 6
- Citric acid
- Clinical trial
- Clopidogrel
- Community
- Coumarin
- Dabigatran
- Dalteparin sodium
- Danaparoid
- Diphenadione
- Dipyridamole
- Direct thrombin inhibitor
- DOI
- Edoxaban
- Endothelium
- Engaging
- Enoxaparin sodium
- Ensembl genome database project
- Entrez
- Ethylenediaminetetraacetic acid
- Factor IX
- Factor X
- FDA
- Fibrin
- Fibrinolysis
- Fondaparinux
- Food and Drug Administration
- GeneCards
- Gene expression
- Gene ontology
- Glycoprotein IIb/IIIa inhibitors
- Glycosaminoglycan
- Gravity bong
- Heparin
- Hirudin
- Homology
- Human genome
- Iloprost
- Laboratory mouse
- LOCUS
- Low molecular weight heparin
- Magazine
- Marrow
- Mediation
- Medical Center
- Metástasis
- Mobile
- Myocardial infarction
- Nafamostat
- National Stroke Awareness Month
- Nucleoside
- Nucleotide
- Oligosaccharide
- Online Mendelian Inheritance in Man
- Oxalate
- P2
- P2 receptor
- P2Y12
- Phases of clinical research
- Phenindione
- Phenprocoumon
- Phosphodiesterase inhibitor
- Plasmin
- Plasminogen activator inhibitor-1
- PMC
- Prasugrel
- Prostacyclin
- Protein C
- PubMed
- Pulmonary embolism
- Receptor
- REG1
- Rivaroxaban
- Serine protease
- Signal
- Streptokinase
- Stroke
- Stroke awareness
- Tenecteplase
- The brain
- Thrombin
- Thrombolysis
- Ticagrelor
- Tissue plasminogen activator
- Treprostinil
- UniProt
- Vitamin K antagonist
- Warfarin
- WHO Model List of Essential Medicines
- Wikidata